Aim: To determine the safety and efficacy of self-administered outpatient parenteral antibiotic treatment (S-OPAT) within a hospitalization-at-home (HaH) program to manage a urinary tract infection (UTI) in patients referred directly from a hospital ED.
Introduction
Urinary tract infection (UTI) is one of the most commonly treated pathologies in hospital emergency departments (EDs). UTIs comprise approximately 22% of all infectious processes and are a common reason for hospital admission (1) . The growing prevalence of multidrug resistant microorganisms (MRM) as a cause of UTI and other infections currently entails a severe public health problem (2) . The consumption of resources arising from the treatment of UTI is very high, and in the United States alone, it is responsible for approximately 100,00 hospital admissions out of more than 1 million visits to EDs and a cost of more than US$1 billion (3). All these circumstances make UTI a complex clinical entity and a challenge for health care professionals.
However, alternative care systems that avoid the patient admission into a conventional hospital ward should mean improved efficiency. In this sense, some models denominated the outpatient parenteral antimicrobial therapy (OPAT), which is based on the administration of parenteral antibiotics at home, have obtained excellent results in terms of safety and efficacy in the context of clinically stable infectious processes (4) . Among them, there is a variant known as self-administered OPAT (S-OPAT) in which health care staff trains carers or the patient to administer parenteral medication, which raises the efficiency even more, given that the costs arising from nursing visits are vastly reduced (5).
Moreover, in Spain, there are hospitalization-at-home (HaH) units, a more complex alternative care resource than OPAT, which offer a diagnostic and therapeutic support at home similar to the one provided on the ward and can treat any clinical process with hospital admission criteria. In these units, not only antimicrobials are administered parenterally but also other drugs are administered intravenously. Serum therapy, prior oxygen therapy, analgesics, antipyretics, and nebulized medications can be administered, blood derivatives are transfused, and all kinds of biological samples can be collected at home (6) .
The primary objective of our study is to determine the safety and efficacy of UTI treatment by means of an S-OPAT regimen supported within the scope of a HaH program in patients referred directly from ED.
Materials and Methods

Study design
This was a retrospective, observational study of a series of patients. The study was approved by the Ethics Committee of the Autonomous Community of Cantabria (2017.249).
Study context and population
In Marqués de Valdecilla University Hospital, a third level hospital with an approximate capacity of 900 beds, all episodes of patients diagnosed with UTI with hospital admission criteria according to the European Association of Urology, (7) who received S-OPAT in the HaH unit immediately after being treated in the ED during a two-year period (2015-2016) were analyzed.
Data collection
Epidemiological (sex, age), clinical (comorbidity, nephrourological history, the type of UTI, the type of antibiotic, S-OPAT duration), and microbiological study variables were obtained from the clinical history records (on paper and/or electronic) of the hospital and were included in a Microsoft Excel-like database.
Objectives
The objectives were to determine safety (domiciliary mortality, complications that obliged an unexpected return to hospital, and subsequent intra-hospital death) and efficacy (healing rate, recurrence of the UTI) of this care modality.
Statistical analysis
Variables were analyzed with the statistical software package Statistical Package for Social Sciences version 11.5 (SPSS Inc.; Chicago, IL, USA). A descriptive analysis was performed; quantitative and qualitative variables were expressed as the mean±standard deviation and percentage and proportions, respectively.
Results
Characteristics of the population studied During the study period, emergency doctors admitted 1,394 episodes of UTI, of which 268 (19.2%) were in compliance with the HaH admission criteria, whereby they were transferred home to complete the stipulated therapeutic plan ( Table 1 ). The description of the basal characteristics of patients and the most important microbiological characteristics of UTI episodes are summarized in Table 2 . 
Safety and effectiveness
The results concerning safety and efficacy are summarized in Table 3 . Regarding safety, during S-OPAT, only one death occurred at home because of broncho-aspiration in an extremely elderly patient with a highly deteriorated basal functional situation. In 16.1% of patients, a clinical complication appeared mostly unrelated to infection. Most of these (79.1%) could be resolved at home. A total of 20 patients had to return to hospital, nine because of major medical complications. Four of these complications may have been related to the infectious process (two episodes of exacerbation of chronic renal failure, one epileptic crisis probably following the administration of ertapenem, and one case of therapeutic failure despite theoretically correct initial treatment). Another eight patients returned because of sociofamilial problems that made it impossible to continue the S-OPAT, and a further three returned because of having scheduled surgery unrelated to the UTI. One of the patients who returned died for reasons unrelated to UTI.
As for efficacy, once the 11 patients that returned to hospital for socio-familial reasons and scheduled surgery were excluded, the healing rate attained in those in whom it was possible to complete the S-OPAT program was 96.5%. During the first month following discharge from HaH, 11 (4.4%) patients who completed S-OPAT were readmitted because of the recurrence of the UTI. A further six did so for reasons outside the scope of the UTI (two because of bronchoaspiration, one because of superinfected pressure ulcers, and three because of scheduled surgery). 
Morganella morganii 1 (5.2)
Documented MDR microorganisms (n, %)
Total positive MDR microorganisms in the 175 isolates (n, %)
(15.4)
Escherichia coli ESBL 10 (37.0) 
Discussion
This work reveals that despite the UTI complexity because of its various symptoms (fever, pain, dehydration, etc.) at the time of diagnosis, it is possible to safely and effectively perform S-OPAT within a HaH unit. To the best of our knowledge, our work is novel as there are no precedents in the literature that dealt with this issue.
Thanks to the HaH unit, the ED avoided the admission of almost one in every five patients diagnosed with UTI with hospital admission criteria and obtained from the outset, which had a positive impact on the management of hospital resources (relief of the ED congestion, improved availability of beds in the traditional hospital ward, etc.). In this context, in accordance with recent publications that advocate the need to set out new care strategies that would help to homogenize hospital admission decisions, the HaH could reduce the costs significantly (8) . Therefore, Stuck et al. recently concluded that emergency physicians are highly receptive to referring patients to HaH units, but they demand that referral processes be quick (9) .
Data obtained in our series share the epidemiological similarities with those observed in recent literature, and they revealed the increasingly more common onset of the MRM strains as causal UTI factors (9) . From the microbiological point of view, our series is notable because of its extremely high index of collection of urine cultures with more than 60% coming back as positive; these figures are higher than those found in the literature (approximately 41%) (10) . E. coli turned out to be the most commonly isolated microorganism, both in urine and blood cultures. The high presence of MRM strains in our series (more than 15% of isolates), well above the 5% from other studies, (11) highlights the important work of our HaH unit with the aim of limiting their dissemination within the hospital setting.
Our S-OPAT program was extremely safe because only a little more than 3% of patients returned to hospital because of major medical complications. The low mortality rate turned out to be more than assumable, given the baseline characteristics of the deceased patient. The results obtained in terms of efficacy were satisfactory, and a healing rate similar to the one published recently by a Spanish group that applied traditional OPAT (12) was attained.
The success of our S-OPAT model in this context is most likely due to several reasons. First, the close collaboration with the ED staff fosters an effective process of patients' home referral (9) . However, early administration of antimicrobials and collection of microbiological samples favored a better clinical course in patients, something corroborated by the abundant literature that revealed that both actions improve the prognosis of infectious processes seen in ED (13) . Finally, appropriate selection of patients and the efficacy of our HaH unit when responding to any complication at home were essential for the program's success.
Study limitations
We believe the internal validity of our work is high because there was no loss of information. Moreover, the S-OPAT model has been supported in a HaH unit with more than 30 years of experience. However, this study has some limitations, derived specifically from the concrete features of our HaH unit, which can hinder its practical application in other contexts. Such specificities would be their dependence on a tertiary hospital, their close daily collaboration with the ED for referral of any kind of HaH subsidiary process, and finally, their major capacity to provide with their own health care personnel and 24 hours a day, a fast response to any clinical complication of the patient in their own home. All of this can hinder the extrapolation of our conclusions to other medical care contexts. 
Conclusion
To conclude, the S-OPAT model supported within a HaH unit is safe and effective in the treatment of complex UTI cases, referred directly from the ED. This also constitutes a doubly useful care tool for the hospital by improving the overall bed management and avoiding the intra-hospital dissemination of MRM strains.
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